Methods of Cancer Diagnosis, Therapy, and Prognosis - Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma

PThis sixth volume in the series STRONGMethods of Cancer Diagnosis, Therapy, and Prognosis/STRONG discusses Ovarian Cancer, Renal Cancer, Urogenitary Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included./P PThis fully illustrated volume/P UL LIIdentifies biomarkers based on genetic alterations for clear cell ovarian adenocarcinoma./LI LIIdentifies subgroups of ovarian cancer by using differential gene expression./LI LIIncludes the application of the power-Doppler imaging for distinguishing benign from malignant complex adrenal masses in ovarian cancer./LI LIEmphasizes the advantage of using cytoreduction surgery for diagnosing advanced ovarian cancer./LI LIProvides details on the treatment of kidney cancer with radiofrequency ablation, surgery, and chemotherapy./LI LIExplains the use of immunohistochemistry for diagnosing adenomatoid tumor of the adrenal gland./LI LIDiscusses the chemotherapy of testicular cancer and related second primary tumors./LI LIIncludes the diagnosis of urothelial bladder cancer with urine-based tumor markers./LI LIExplains the use of immunohistochemistry and MRI for diagnosing uterine cervical cancer and describes the staging of this cancer using PET alone or PET/CT./LI LIDescribes the localization of malignant melanoma using FDG-PET/CT./LI LIExplains the use of prognostic receptors for nonmelanoma skin cancer./LI LIDetails the treatment of multiple myeloma using immunotherapy, radiotherapy, and targeted radionuclide therapy./LI LIPresents diagnostic immunohistochemistry of synovial and Kaposi's sarcoma./LI/UL PThe technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice.
The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of these different types of cancer./P PProfessor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology./P